Robotic Level IV Inferior Vena Cava Thrombectomy Using an Intrapericardial Control Technique: Is It Safe without Cardiopulmonary Bypass?

Qingbo Huang,Guodong Zhao,Yonghui Chen,Peng Wu,Shuanglei Li,Cheng Peng,Kan Liu,Hongkai Yu,Yubo Gao,Cangsong Xiao,Qiang Fu,Hao Shen,Qiuyang Li,Nan Li,Haiyi Wang,Xeng Inn Fam,Baojun Wang,Rong Liu,Xu Zhang,and Xin Ma
DOI: https://doi.org/10.1097/ju.0000000000002952
2022-10-06
Abstract:To introduce an intrapericardial control technique using robotic approach in the surgical treatment of renal tumor with level IV Inferior vena cava (IVC) thrombus to decrease the severe complications associated with cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA). Eight patients with level IV IVC thrombi not extending into the atrium underwent transabdominal-transdiaphragmatic robotic assisted IVC thrombectomy (RA-IVCT) obviating CPB/DHCA (CPB-free group) by an expert team comprising urologic, hepatobiliary, and cardiovascular surgeons. The central diaphragm tendon and pericardium were transabdominally dissected until the intrapericardial IVC were exposed and looped proximal to the cranial end of the thrombi under intraoperative ultrasound guidance. As controls, 14 patients who underwent RA-ICVT with CPB (CPB group) and 25 patients who underwent open thrombectomy with CBP/DHCA (CBP/DHCA group) were included. Clinicopathologic, operative, and survival outcomes were retrospectively analyzed. Eight RA-IVCTs were successfully performed without CPB, with one open conversion. The median operation time, and first porta hepatis occlusion time were shorter, and estimated blood loss were lower in CPB-free group as compared to the CPB group (540 vs. 586.5 min, 16.5 vs. 38.5. min, and 2050 vs. 3500ml, respectively). Severe complications (level IV-V) were also lower in the CPB-free group than that in CPB and CBP/DHCA groups (25% vs. 50% vs. 40%). Oncologic outcomes were comparable among the three groups in the short-term follow-up. Pure transabdominal-transdiaphragmatic RA-IVCT without CPB/DHCA represents as an alternative minimally invasive approach for selected level IV IVC thrombi.
urology & nephrology
What problem does this paper attempt to address?